Get the latest news on IntelliPharmaCeutics Intl stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on IPCIQ performance

Latest IntelliPharmaCeutics Intl Stock News | OTC:IPCIQ | Benzinga

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

INTELLIPHARMACEUTICS INTL by Intellipharmaceutics International Inc.

Comments

IntelliPharmaCeutics Intl Stock News

News

Latest IntelliPharmaCeutics Intl Stock News | OTC:IPCIQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga